Issue link: https://www.e-digitaleditions.com/i/1067339
verification for products made according to best practices for GMO avoidance. The capsules pro- tect sensitive ingredients, such as probiotics, from stomach acid and provide taste- and odor-masking and reduce bad aftertastes. In other news, Lonza opened its Collaborative Innovation Center in Haifa Life Science Park, Israel. The 10,764-square-foot facility will act as a hub for partnerships to identify and accelerate new solutions for bio- pharma manufacturing. The site includes lab space equipped with bioprocessing and analytical equip- ment. Lonza plans to provide fund- ing and in-house expertise at the site to promote collaborative research into strategic areas of application rel- evant to a variety of biopharma development needs. PCI expands clinical service facility ROCKFORD, IL—PCI is expand- ing its clinical services facility to pro- vide 30,000 square feet of additional space for primary and secondary packaging and labeling operations for investigational medicinal prod- ucts. The facility is one of two such sites operated by the company in the US. The company anticipates open- ing the expansion in late 2019. Hovione expands oral dosage production LOURES, Portugal—Hovione, a pharmaceutical CDMO, announced plans to expand its oral dosage pro- duction capacity, including adding commercial-scale equipment for blending, tableting, and coating. The new equipment will operate alongside existing smaller-scale equip- ment to take products through the development process to market. The expansion is part of the CDMO's five-year expansion project that began in 2016. ducted by NSF. (www.nsf.org, 734 769 8010). Chemical Development & Scale-Up in the Fine Chemical & Pharmaceuti- cal Industries. March 19-21 in Milan, Italy. Conducted by Scientific Update. (www.scientificupdate.com, +44 1435 873 062). Hands-on Tablet Press Training Basics. March 19-22 in Cleveland, OH. Conducted by Techceuticals. (www. techceuticals.com, 216 658 8038). Stability Programs for Determining Product Shelf Life. March 20-21 in Malvern, PA. Conducted by Center for Professional Innovation & Educa- tion. (www.cfpie.com, 610 648 7550). International Conference on Toxicol- ogy and Risk Assessment. March 20-22 in Frankfurt, Germany. Con- ducted by Madridge Conferences. (toxicology.madridge.com, contact@ madridge.com). Pharmaceutical Legislation Update. March 21 in Amsterdam, the Nether- lands. Conducted by NSF. (www.nsf. org, 734 769 8010). Pharma Forum 2019. March 24-27 in New York, NY. Conducted by CBI. (www.cbinet.com/pharmaforum, 800 817 8601). Holistic Medicine and Nursing Care. March 25-26 in Orlando FL. Con- ducted by ConferenceSeries. (holistic medicine.conferenceseries.com, 888 843 8169). Probiotics, Functional Foods & Nutraceuticals. March 25-26 in Hong Kong. Conducted by Confer- enceSeries. (probioticscongress. conferenceseries.com, 800 216 6499). P h a r m a c o v i g i l a n c e A u d i t a n d Inspections Conference. March 25-26 in Philadelphia, PA. Con- ducted by ExL. (exlevents.com/ pv-audit-and-inspections/, 866 207 6528). Analytical Methods Validation for FDA Compliance. March 25-27 in New Brunswick, NJ. Conducted by the Center for Professional Advancement. (www.cfpa.com, 732 238 1600). Drug Formulation, Solubility & Bio- availability. March 25-27 in Boston, MA. Conducted by ExL Events. (exlevents.com/bioavailability/, 866 207 6528). Pharmaceutical GMP Audits and Self-Inspections. March 25-29 in Manchester, UK. Conducted by NSF. (www.nsf.org, 734 769 8010). OTC Stability Program for FDA Compliance. March 28-29 in New Brunswick, NJ. Conducted by the Center for Professional Advancement. (www.cfpa.com, 732 238 1600). supplier news Metrics doubles packaging capacity at New Jersey site G R E E N V I L L E , N J — M e t r i c s Contract Services, a division of Mayne Pharma, has successfully qualified two commercial bottling lines for serialization at its solid oral dose commercial manufacturing site in Greenville, NJ. In addition to dou- bling the site's packaging capacity, the new lines allow the company to comply with the US Drug Supply Chain Security Act, which became subject to enforcement in November 2018. According to Metrics, the facility has space available to add a third commercial packaging line in the future. Recro Gainesville opens high- potency material processing site G A I N E S V I L L E , G A — R e c r o Gainesville, a solid oral dosage CDMO, has opened a new 24,000- square-foot facility near its existing 97,000-square-foot pharmaceutical CDMO plant. The addition includes a high-potency material processing space and will support clients with development through commercializa- tion for high-potency compounds. Capsugel product verified by Non-GMO Project, opens hub GREENWOOD, SC—The Non- GMO Project organization has veri- fied Lonza's Capsugel DRcaps cap- sules as non-GMO products. The organization provides independent Tablets & Capsules January 2019 49 Subscribe today at tabletscapsules.com